Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Toa Confident in Ensuring Stable Supply of Symbicort Generic with Expertise in Dry Powder Inhaler Manufacturing
March 8, 2019
- Teva Takeda Discloses Info on Producing Countries of Its Generic APIs
March 7, 2019
- Sawai’s Generic Abilify Approved for Depression
March 7, 2019
- Xofluza Filed in US to Treat Patients at High Risk of Flu-Related Complications: Shionogi
March 7, 2019
- Japan’s 1st Drug to Reduce Alcohol Consumption Launched: Otsuka
March 6, 2019
- Alcon Pharma to Be Integrated into Novartis Japan in April
March 6, 2019
- Bayer Submits Prostate Cancer Drug Darolutamide in Japan
March 6, 2019
- Pfizer Japan Logs 2.6% Growth in FY2018, No Job Cut Planned: Chief
March 6, 2019
- Sawai Recalls GI Drug after Doping Substance Found
March 6, 2019
- Fujifilm, Tokyo Medical and Dental Univ. Ink Regenerative Medicine Pact for Meniscal Injury
March 6, 2019
- Osteoporosis Drug Evenity Now Available: Amgen Astellas
March 5, 2019
- ASKA to Relocate Kawasaki Research Center to Shonan iPark; 1st Non-Takeda Pharma Tenant
March 5, 2019
- Teijin Pharma’s Feburic Now Available in China
March 5, 2019
- Sumitomo Dainippon to Bolster Functions in Singapore Subsidiary; Maximizing South East Asian Biz
March 5, 2019
- Pfizer Japan Rolls Out EGFR Inhibitor Vizimpro
March 4, 2019
- Kyowa Kirin Resubmits Istradefylline for US Approval for 1st time in 12 Years, Based on Japanese Data
March 4, 2019
- Nichi-Iko Scoops Up FDA-Approved Manufacturing Plant in US from Danish Pharma
March 4, 2019
- Shionogi Strikes Malaria Pact with Nagasaki University
March 1, 2019
- Kaken Grabs Japan Rights to Arbor’s Head Lice Drug
March 1, 2019
- Taisho to Snap Up More Shares in Vietnam’s DHG, Boost Southeast Asian Biz
March 1, 2019
ページ
More than a year after Dupixent (dupilumab) became the first antibody therapy approved for COPD in Japan, drug makers are…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…